Skip to main content

Kutzkey Tim

In the past year, 6 open-market purchase filings worth $41.1M and 3 sale filings worth $5.93M.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$41.1M
6 filings
Sold
$5.93M
3 filings
Net
+$35.2M
Bought minus sold
Companies
3
With open-market trades

Trades

Every Form 4 that lists Kutzkey Tim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

EIKN Eikon Therapeutics, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2026 (view filing)4:33 PM ETSep 35 daysSvennilson Peter and 7 others10% OwnerPPurchase+89.2K$11.56+$1.03MNew position89.2K after
Feb 9, 2026 (view filing)9:19 PM ETFeb 63 daysSvennilson Peter and 7 others10% OwnerPPurchase+2.12M$18.00+$38.1MNew position1.32M after3 lots

TNYA Tenaya Therapeutics, Inc.

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 26, 2026 (view filing)4:23 PM ETFeb 24-252 daysSvennilson Peter and 7 others10% OwnerSSale−4.17M$0.5708−$2.38M−100.0%0 after4 lots
Feb 24, 2026 (view filing)4:13 PM ETFeb 20-234 daysSvennilson Peter and 7 others10% OwnerSSale−829.7K$0.6084−$504.8K−27.3%2.21M after4 lots
Feb 12, 2026 (view filing)5:19 PM ETFeb 10-112 daysSvennilson Peter and 7 others10% OwnerSSale−4.40M$0.6914−$3.04M−62.4%2.65M after4 lots

SRZN Surrozen, Inc.

Director, 10% Owner7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 20, 2026 (view filing)Jan 15-205 daysKutzkey TimDirector, 10% OwnerPPurchase+32.5K$19.74+$641.6K+3.3%1.02M after6 lots
Jan 15, 2026 (view filing)Jan 13-142 daysKutzkey TimDirector, 10% OwnerPPurchase+18.0K$19.86+$357.3K+1.8%999.4K after4 lots
Jan 8, 2026 (view filing)Jan 62 daysKutzkey TimDirector, 10% OwnerPPurchase+15.1K$19.89+$300.3K+1.5%989.9K after2 lots
Dec 8, 2025 (view filing)Dec 4-54 daysKutzkey TimDirector, 10% OwnerPPurchase+36.1K$19.22+$694.8K+3.8%981.9K after4 lots
Dec 2, 2025 (view filing)Nov 1319 daysLateKutzkey TimDirector, 10% OwnerPPurchase+315.5K$12.65+$3.99M+48.7%962.7K after2 lotsDuplicate filing
Apr 17, 2024 (view filing)Apr 413 daysKutzkey TimDirector, 10% OwnerPPurchase+193.5K$15.50+$3.00M+145.0%327.0K afterAmended2 lots
Apr 8, 2024 (view filing)Apr 44 daysKutzkey TimDirector, 10% OwnerPPurchase+1.90M–––397.8K afterFrom originalDerivative8 lots

NGM NGM Biopharmaceuticals Inc

10% Owner22 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2023 (view filing)4:28 PM ETNov 15-162 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+22.6K$0.6852+$15.5K+2.4%949.9K after2 lots
Feb 1, 2023 (view filing)4:29 PM ETJan 30-312 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+184.3K$5.00+$921.1K+24.8%927.2K after2 lots
Jan 25, 2023 (view filing)4:31 PM ETJan 232 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+9.90K$5.00+$49.5K+1.4%743.0K after
Jan 23, 2023 (view filing)4:19 PM ETJan 19-204 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+38.1K$5.00+$190.6K+5.5%733.1K after2 lots
Jan 17, 2023 (view filing)4:32 PM ETJan 125 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+5.38K$4.95+$26.6K+0.8%694.9K after
Jan 12, 2023 (view filing)4:35 PM ETJan 10-112 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+309.1K$4.79+$1.48M+81.2%689.5K after2 lots
Dec 14, 2022 (view filing)4:28 PM ETDec 122 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+300$4.98+$1.49K+0.1%380.5K after
Nov 23, 2022 (view filing)4:14 PM ETNov 21-222 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+40.3K$5.00+$201.6K+11.9%380.2K after2 lots
Nov 7, 2022 (view filing)4:17 PM ETNov 3-44 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+139.1K$4.92+$684.4K+69.3%339.8K after2 lots
Oct 31, 2022 (view filing)5:17 PM ETOct 274 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+76.9K$4.86+$373.6K+62.1%200.7K after

See all 22 trades at NGM

RAPT RAPT Therapeutics, Inc.

10% Owner8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 27, 2022 (view filing)4:24 PM ETMay 252 daysGoeddel David V and 9 others10% OwnerPPurchase+1.90K$12.45+$23.7K+4.7%42.2K after2 lots
May 25, 2022 (view filing)4:19 PM ETMay 23-242 daysGoeddel David V and 9 others10% OwnerPPurchase+26.6K$12.19+$323.7K+170.5%42.1K after4 lots
May 12, 2022 (view filing)5:28 PM ETMay 102 daysGoeddel David V and 9 others10% OwnerPPurchase+1.25M$10.67+$13.3MNew position41.3K after2 lots
Sep 29, 2021 (view filing)4:58 PM ETSep 272 daysGoeddel David V and 9 others10% OwnerSSale−9.24K$34.57−$319.4K−100.0%0 after3 lots
Sep 16, 2021 (view filing)5:16 PM ETSep 14-152 daysGoeddel David V and 9 others10% OwnerSSale−181.2K$37.01−$6.71M−100.0%0 after13 lots
Sep 14, 2021 (view filing)5:31 PM ETSep 10-134 daysGoeddel David V and 9 others10% OwnerSSale−36.1K$35.22−$1.27M−49.6%36.6K after6 lots
Sep 3, 2021 (view filing)4:09 PM ETSep 1-22 daysGoeddel David V and 9 others10% OwnerSSale−68.8K$35.34−$2.43M−100.0%0 after6 lots
Aug 24, 2021 (view filing)8:52 PM ETAug 20-244 daysGoeddel David V and 9 others10% OwnerSSale−95.7K$31.30−$3.00M−100.0%0 after18 lots